Skip to content

Clinical trials

Recruiting Phase 1/2 Ovarian Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Status: Recruiting Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20181
20191
20204
202110
20224
202310
202414
202514
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting74

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Biotech4
AstraZeneca3
Essen Biotech3
Gilead Sciences2
Hadassah Medical Organization2
Jacobio Pharmaceuticals Co., Ltd.2
Regeneron Pharmaceuticals2
Shenzhen Ionova Life Sciences Co., Ltd.2
University of California, Irvine2
858 Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms74
Endometrial Neoplasms27
Breast Neoplasms24
Colorectal Neoplasms21
Carcinoma, Non-Small-Cell Lung17
Pancreatic Neoplasms17
Uterine Cervical Neoplasms17
Prostatic Neoplasms15
Stomach Neoplasms15
Neoplasms14

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.